A detailed history of Macquarie Group LTD transactions in Twist Bioscience Corp stock. As of the latest transaction made, Macquarie Group LTD holds 58,016 shares of TWST stock, worth $2.69 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
58,016
Holding current value
$2.69 Million
% of portfolio
0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$27.95 - $53.0 $1.62 Million - $3.07 Million
58,016 New
58,016 $2.86 Million
Q4 2022

Feb 21, 2023

SELL
$21.92 - $39.37 $156,223 - $280,589
-7,127 Reduced 43.51%
9,252 $220,000
Q3 2022

Nov 14, 2022

SELL
$33.44 - $56.56 $357,139 - $604,060
-10,680 Reduced 39.47%
16,379 $599,000
Q2 2022

Aug 15, 2022

SELL
$26.2 - $54.0 $61,019 - $125,766
-2,329 Reduced 7.93%
27,059 $946,000
Q1 2022

May 16, 2022

SELL
$38.58 - $83.27 $4.76 Million - $10.3 Million
-123,384 Reduced 80.76%
29,388 $1.45 Million
Q4 2021

Feb 11, 2022

SELL
$75.47 - $135.88 $900,508 - $1.62 Million
-11,932 Reduced 7.24%
152,772 $11.8 Million
Q3 2021

Nov 12, 2021

BUY
$95.64 - $131.48 $5.64 Million - $7.75 Million
58,925 Added 55.71%
164,704 $17.6 Million
Q2 2021

Aug 13, 2021

BUY
$88.13 - $142.06 $7.56 Million - $12.2 Million
85,811 Added 429.74%
105,779 $14.1 Million
Q1 2021

May 14, 2021

BUY
$105.48 - $207.97 $1.99 Million - $3.92 Million
18,850 Added 1686.05%
19,968 $2.47 Million
Q4 2020

Feb 16, 2021

SELL
$76.64 - $167.89 $30,579 - $66,988
-399 Reduced 26.3%
1,118 $158,000
Q3 2020

Nov 13, 2020

SELL
$45.46 - $78.79 $3.01 Million - $5.22 Million
-66,239 Reduced 97.76%
1,517 $115,000
Q2 2020

Aug 11, 2020

BUY
$26.4 - $45.3 $1.74 Million - $2.99 Million
66,020 Added 3803.0%
67,756 $3.07 Million
Q1 2020

May 15, 2020

BUY
$19.71 - $35.15 $34,216 - $61,020
1,736 New
1,736 $53,000

Others Institutions Holding TWST

About Twist Bioscience Corp


  • Ticker TWST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 56,363,500
  • Market Cap $2.61B
  • Description
  • Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...
More about TWST
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.